Three pharmaceutical companies announce a shift away from traditional finance by accepting Bitcoin | Posted by Muhamad Yusup / Cupi Crypto | Coins | December 2024
Bitcoin continues to make waves in the business world. This time, three major pharmaceutical companies, including Enlivex Therapeutics, Acurx Pharmaceuticals, and Hoth Therapeutics, announced plans to invest in the world’s largest cryptocurrency.
Three companies plan to allocate. USD 1 million Each buys Bitcoin. This move represents a shift from traditional finance to a more modern and innovative approach.
“What we have experienced over the past three to four years has led us to believe that further instrumental investment in Bitcoin is essential,” said Oren Hershkovitz, CEO of Enlivex.
Why do pharmaceutical companies choose Bitcoin?
Factors driving pharmaceutical companies to invest in Bitcoin include:
- Inflation Prevention: Bitcoin is considered a “safe haven” asset that is resistant to inflation. Because of its limited supply, it is less susceptible to devaluation than fiat currency.
- Global economic uncertainty: Global economic uncertainty, war, and geopolitical crises are forcing companies to seek more stable and diversified investment alternatives.
- Asset Diversification: Adding Bitcoin to your investment portfolio…